http://info.cancerresearchuk.org/news/podcast/podcastarchive/february-2012-podcast This month - dye spots early signs of oesophageal cancer, prostate cancer drug rejected by NICE, faulty gene linked to better ovarian cancer survival, new drug trial to treat childhood leukaemia, and finally, we speak to our chief executive Dr Harpal Kumar as Cancer Research UK celebrates its tenth birthday.
Be the first to comment